MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
19 hedge funds and large institutions have $334K invested in Stealth BioTherapeutics Corp. ADS in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+6
Holders Change %
+46.15%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
Renaissance Technologies
New York
|
$4K |
2 |
Morgan Stanley
New York
|
$0 |
3 |
Citigroup
New York
|
$0 |
4 |
Two Sigma Advisers
New York
|
$4K |